Literature DB >> 33225231

Type 2 diabetes prevalence in Pakistan: what is driving this? Clues from subgroup analysis of normal weight individuals in diabetes prevalence survey of Pakistan.

Azizul Hasan Aamir1, Zia Ul-Haq2,3, Sheraz Fazid2, Basharat Hussain Shah2, Abbas Raza4, Ali Jawa5, Saeed A Mahar6, Ibrar Ahmad7, Faisal Masood Qureshi8, Adrian H Heald9,10.   

Abstract

BACKGROUND: Type 2 diabetes mellitus (T2DM) is a global health tissue. We determined factors relating to the likelihood of developing T2DM in normal BMI individuals.
METHODOLOGY: This was a cross-sectional community-based representative survey, of people aged ≥20 years in Pakistan, using HBA1c as the screening tool. The prevalence of T2DM/prediabetes in people having normal BMI together with associated risk factors was estimated.
RESULTS: Of 6824 normal BMI individuals, there was still a high prevalence of T2DM 14.92% and in underweight at 10.14% (overall prevalence 16.96%). Corresponding rates for prediabetes for the normal BMI category: 9.79% and underweight 8.99%. Multivariate logistic regression modeling for normal BMI individuals, showed a significantly increased risk of T2DM with increasing age (odds ratio [OR] 2.1, 3.3, 4.5 and 4.8, P < 0.001 for 31-40, 41-50, 51-60 and 61 years and above respectively, compared to age decade 20-30 years). Similarly, there was a significantly high risk of T2DM with lower education level [OR for no vs graduate 2.4, 95% confidence interval (CI) 1.5-3.8]. There was a significantly increased risk of T2DM in individuals having a positive family history [OR 4.3 (95% CI 7.0-11.5)]. Overall the influence of overweight/obese on T2DM occurrence (20% increased risk) was much less than in other regions of the world.
CONCLUSION: There are higher than expected rates of T2DM/prediabetes in Pakistani ethnicity normal BMI individuals. Targeted screening of older individuals with historical lack of educational opportunity, with a family history of T2DM even if of normal BMI may result in a significant benefit in the Pakistan population.
Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Keywords:  HbA1c; Pakistan; diabetes; normal BMI; prevalence; type 2 diabetes mellitus

Year:  2020        PMID: 33225231      PMCID: PMC7673776          DOI: 10.1097/XCE.0000000000000212

Source DB:  PubMed          Journal:  Cardiovasc Endocrinol Metab        ISSN: 2574-0954


  13 in total

1.  Obesity: preventing and managing the global epidemic. Report of a WHO consultation.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  2000

2.  The burden of mortality attributable to diabetes: realistic estimates for the year 2000.

Authors:  Gojka Roglic; Nigel Unwin; Peter H Bennett; Colin Mathers; Jaakko Tuomilehto; Satyajit Nag; Vincent Connolly; Hilary King
Journal:  Diabetes Care       Date:  2005-09       Impact factor: 19.112

3.  International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes.

Authors: 
Journal:  Diabetes Care       Date:  2009-06-05       Impact factor: 17.152

4.  Genetic evidence for a normal-weight "metabolically obese" phenotype linking insulin resistance, hypertension, coronary artery disease, and type 2 diabetes.

Authors:  Hanieh Yaghootkar; Robert A Scott; Charles C White; Weihua Zhang; Elizabeth Speliotes; Patricia B Munroe; Georg B Ehret; Joshua C Bis; Caroline S Fox; Mark Walker; Ingrid B Borecki; Joshua W Knowles; Laura Yerges-Armstrong; Claes Ohlsson; John R B Perry; John C Chambers; Jaspal S Kooner; Nora Franceschini; Claudia Langenberg; Marie-France Hivert; Zari Dastani; J Brent Richards; Robert K Semple; Timothy M Frayling
Journal:  Diabetes       Date:  2014-07-21       Impact factor: 9.337

5.  Growing burden of diabetes in Pakistan and the possible role of arsenic and pesticides.

Authors:  Haji Bahadar; Sara Mostafalou; Mohammad Abdollahi
Journal:  J Diabetes Metab Disord       Date:  2014-12-14

6.  Diabetes Prevalence Survey of Pakistan (DPS-PAK): prevalence of type 2 diabetes mellitus and prediabetes using HbA1c: a population-based survey from Pakistan.

Authors:  Azizul Hasan Aamir; Zia Ul-Haq; Saeed A Mahar; Faisal Masood Qureshi; Ibrar Ahmad; Ali Jawa; Aisha Sheikh; Abbas Raza; Sheraz Fazid; Zahid Jadoon; Osama Ishtiaq; Nauman Safdar; Hussain Afridi; Adrian H Heald
Journal:  BMJ Open       Date:  2019-02-21       Impact factor: 2.692

7.  The association of body mass index with the risk of type 2 diabetes: a case-control study nested in an electronic health records system in the United States.

Authors:  Michael L Ganz; Neil Wintfeld; Qian Li; Veronica Alas; Jakob Langer; Mette Hammer
Journal:  Diabetol Metab Syndr       Date:  2014-04-03       Impact factor: 3.320

8.  Genetic variants associated with lean and obese type 2 diabetes in a Han Chinese population: A case-control study.

Authors:  Xiaomu Kong; Xiaoyan Xing; Jing Hong; Xuelian Zhang; Wenying Yang
Journal:  Medicine (Baltimore)       Date:  2016-06       Impact factor: 1.889

9.  Abdominal Obesity Indicators: Waist Circumference or Waist-to-hip Ratio in Malaysian Adults Population.

Authors:  Norfazilah Ahmad; Samia Ibrahim Mohamed Adam; Azmawati Mohammed Nawi; Mohd Rohaizat Hassan; Hasanain Faisal Ghazi
Journal:  Int J Prev Med       Date:  2016-06-08

10.  Prevalence of diabetes, pre-diabetes and associated risk factors: second National Diabetes Survey of Pakistan (NDSP), 2016-2017.

Authors:  Abdul Basit; Asher Fawwad; Huma Qureshi; A S Shera
Journal:  BMJ Open       Date:  2018-08-05       Impact factor: 2.692

View more
  2 in total

1.  Effectiveness of health education intervention on diabetes mellitus among the teachers working in public sector schools of Pakistan.

Authors:  Ramesh Kumar; Sidra Rehman; Gul Muhammad Baloch; Muskan Vankwani; Ratana Somrongthong; Sathirakorn Pongpanich
Journal:  BMC Endocr Disord       Date:  2022-07-30       Impact factor: 3.263

2.  COVID-19 among the Pakistani immigrant population in Northern Europe--Incidence and possible causes for infection.

Authors:  Ursula S Goth; Heidi Lyshol; Lars Erik Braaum; Anette Sørensen; Hilde Skjerve
Journal:  J Migr Health       Date:  2022-09-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.